3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-ox adiazoles as S1P receptor agonists

Details for Australian Patent Application No. 2004240586 (hide)

Owner Merck & Co., Inc.

Inventors Lynch, Christopher; Doherty, George A.; Neway, William Edward Iii; Colandrea, Vincent J.; Mills, Sander G.; Hale, Jeffrey J.; Toth, Leslie

Agent Spruson & Ferguson

Pub. Number AU-A-2004240586

PCT Pub. Number WO2004/103279

Priority 60/470,659 15.05.03 US

Filing date 12 May 2004

Wipo publication date 2 December 2004

International Classifications

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/103279 Priority application(s): WO2004/103279

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240592-Echogenic stent

2004240585-Avian combination-vaccine against E.coli and Salmonella